Dr. Reddy's Laboratories Ltd.

factsheet Factsheet
  • Value Research Rating market-capitalisation-info
    4 star
  • Market Capitalisation market-capitalisation-info ₹1,05,692 Cr
  • Price to Earnings Ratio price-to-earning 20.22
  • 12 Month Earnings monthly-earning ₹5,228 Cr

Introducing Stock Ratings

Value Research Rating
4 star
Quality Score fund-quick-summary-circle
8/10
Growth Score fund-quick-summary-circle
8/10
Valuation Score fund-quick-summary-circle
6/10

Dr. Reddy's Laboratories Ltd. Share Price

₹6,335.10

As on 04-Mar-2024 IST

up-down-arrow96.201.54%

  • Prev Close info

    6,238.90

  • Day's Openinfo

    6,240.00

  • Today's Highinfo

    6,439.35

  • Today's Lowinfo

    6,239.00

  • Today's Volumeinfo

    4,39,211

  • 52 Week rangeinfo

    ₹4,309.00 - 6,505.90

Please wait...

Dr. Reddy's Laboratories Ltd. Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Dr. Reddy's Laboratories
9.27 4.89 10.19 42.75 12.06 19.08 8.45
S&P BSE Sensex
2.26 2.48 9.47 23.51 12.82 15.42 13.43
S&P BSE Healthcare
10.16 2.87 14.03 60.22 17.25 20.14 12.53
As on 04-Mar-2024
2023
2022
2021
2020
2019
2018
2017
Dr. Reddy's Laboratories
36.82 -13.64 -6.38 80.77 10.26 8.83 -21.11
S&P BSE Sensex
18.74 4.44 21.99 15.75 14.38 5.87 27.91
S&P BSE Healthcare
36.97 -12.10 20.87 61.45 -3.55 -5.89 0.49

Valuation Score

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Dr. Reddy's Laboratories Ltd. Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Dr. Reddy's Laboratories Ltd.

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis of Dr. Reddy's Laboratories Ltd.

        Other details of Dr. Reddy's Laboratories Ltd.

        Incorporated

        1984

        Chairman

        K Satish Reddy

        Managing Director

        GV Prasad

        Group

        Dr. Reddy's

        Headquarters

        Hyderabad, Telangana

        FAQs for Dr. Reddy's Laboratories Ltd.

        The total asset value of Dr. Reddy's Laboratories Ltd. stood at ₹ 34,809 Cr as on 31-Dec-23

        The share price of Dr. Reddy's Laboratories Ltd. is ₹6,335.10 (NSE) and ₹6,335.95 (BSE) as of 04-Mar-2024 IST. Dr. Reddy's Laboratories Ltd. has given a return of 12.06% in the last 3 years.

        Dr. Reddy's Laboratories Ltd. has a market capitalisation of ₹ 1,05,692 Cr as on 04-Mar-2024. As per Value Research classification, it is a Large Cap company.

        The P/B ratio of Dr. Reddy's Laboratories Ltd. is 3.93 times as on 04-Mar-2024, a -0.02% premium to its peers’ median range of 3.99 times.

        The P/E ratio of Dr. Reddy's Laboratories Ltd. is 20.22 times as on 04-Mar-2024, a -0.53% premium to its peers’ median range of 43.30 times.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Dr. Reddy's Laboratories Ltd. and enter the required number of quantities and click on buy to purchase the shares of Dr. Reddy's Laboratories Ltd..

        Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

        The promoters of Dr. Reddy's Laboratories Ltd. are APS Trust and KALLAM SATISH REDDY HUF. They collectively own 23.9 per cent of the total equity. The chairman of the company is K Satish Reddy

        The promoters of Dr. Reddy's Laboratories Ltd. have pledged 0% of the total equity as on Dec-23.

        Some of the close peers are:

        Company Market Cap(₹ Cr)
        3,73,984
        1,18,731
        93,644
        92,354
        Dr. Reddy's Laboratories Ltd. Ratios
        Return on equity(%)
        21.43
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0.01
        Dividend yield(%)
        0.63

        Yes, TTM profit after tax of Dr. Reddy's Laboratories Ltd. was ₹5,228 Cr.

        Edit peer-selector-edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information ₹1,05,691.98 Cr
        • Revenue (TTM)revenue-information ₹27,212.50 Cr
        • Earnings (TTM) earning-information ₹5,228.20 Cr
        • Cash date-information ₹6,792.90 Cr
        • Total Debt info ₹1,347.20 Cr
        • Promoters' ownership promoters_ownership 26.65%
        • Liquidity liquidity High
        • 52 Week range week-range ₹4,309.00 - 6,505.90
        • Face value face-value ₹5.00
        • Shares outstanding share-outstanding 16,68,13,150
        • 10 Years Aggregate:

          CFO: ₹29,826.30 Cr

          EBITDA: ₹34,787.80 Cr

          Net Profit: ₹21,194.30 Cr

        About The Company

        • Incorporated 1984
        • Chairman K Satish Reddy
        • Managing Director GV Prasad
        • Group Dr. Reddy's
        • Listing key-listing BSE: 500124, NSE: DRREDDY
        • Country India
        • Headquarters headquarters Hyderabad, Telangana
        • Website website www.drreddys.com
        • Business

          Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The...  company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.  Read more